the nerves, including muscarine, pilocarpine, choline and acetylcholine, they found that acetylcholine matched all the criteria – swift disappearance from the body, and blockable by atropine. Further experiments, published in 1926, revealed that the reason acetylcholine seemed to disappear was that it was being broken down by an enzyme, cholinesterase. Loewi and his collaborator E. Navratil found that eserine inhibited this enzyme, stopping the breakdown of acetylcholine and allowing it to continue to interact with receptors. The use of eserine allowed scientists to study the effects of acetylcholine more closely, before it was broken down and disappeared.
The use of eserine had provided valuable information about the mechanism of nerve-signal transmission. This work was recognised by the Nobel Committee in 1936 when it awarded Loewi the Nobel Prize for Medicine and Physiology. As Loewi pointed out in his Nobel Prize lecture, the operational mechanism of an alkaloid had been determined for the first time. The initial work on eserine led to our understanding of how many other compounds, such as the organophosphates used as nerve gases and insecticides, inhibit cholinesterase in humans and insects (see page here ).
Acetylcholine – one of a number of chemicals known as neurotransmitters – is released predominantly by nerves in the parasympathetic nervous system or PN, the ‘rest and digest’ system that regulates fluids such as tears and saliva (though it is also found in both the sympathetic and central nervous systems). Eserine therefore mainly affects the PN. Another of the PN’s roles is stimulating contractions of smooth muscle – in the gastrointestinal tract (allowing food to be squeezed through the gut), in the urinary tract and in the eye, as well as decreasing heart rate and relaxing the smooth muscles of blood vessels.
The breakdown of acetylcholine after it has performed its task is vital. To stop receptors from being constantly activated, and to allow repeat signals to be sent to the same site, theacetylcholine must be removed from the binding site so the receptor is ready to receive more signals. The body uses enzymes, cholinesterases, to break up the acetylcholine, using water to cleave chemical bonds and leave two compounds, acetate and choline, neither of which will interact with the receptor site; in other words, going back to our ‘lock and key’ analogy (see page here ), the key is removed from the lock, leaving it ready for the next one to enter.
The human body has two types of cholinesterase enzymes: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). AChE acts almost exclusively on acetylcholine, and is predominantly found in the muscles and brain. The body contains more of the BChE enzyme, though, which is distributed throughout the body. The BChE lock can be opened by several different molecular keys, whereas the AChE lock is specific to the acetylcholine one. BChE acts on a range of compounds, including aspirin, cocaine and heroin, breaking them down and limiting the amount of cholinergic 50 toxins that can reach the brain.
Eserine binds to AChE as if it were acetylcholine, but the structural differences between the two compounds means a different chemical reaction then takes place. The eserine is broken up by the enzyme but only slowly, and in the process a fragment of the eserine structure known as a carbamate unit is transferred to the active site of the enzyme. With the carbamate present, the enzyme cannot carry out its normal function and is effectively inactive. It is as though a key has broken in the lock and a fragment of it has got stuck, so that no other keys will fit in the lock until the fragment is removed. The enzyme can be regenerated by having the carbamate removed by another enzyme, but this process is also slow. While the AChE is out of action, acetylcholine will continue to interact with the nerve receptors, and will stimulate them.
Eserine is classified as
The use of eserine had provided valuable information about the mechanism of nerve-signal transmission. This work was recognised by the Nobel Committee in 1936 when it awarded Loewi the Nobel Prize for Medicine and Physiology. As Loewi pointed out in his Nobel Prize lecture, the operational mechanism of an alkaloid had been determined for the first time. The initial work on eserine led to our understanding of how many other compounds, such as the organophosphates used as nerve gases and insecticides, inhibit cholinesterase in humans and insects (see page here ).
Acetylcholine – one of a number of chemicals known as neurotransmitters – is released predominantly by nerves in the parasympathetic nervous system or PN, the ‘rest and digest’ system that regulates fluids such as tears and saliva (though it is also found in both the sympathetic and central nervous systems). Eserine therefore mainly affects the PN. Another of the PN’s roles is stimulating contractions of smooth muscle – in the gastrointestinal tract (allowing food to be squeezed through the gut), in the urinary tract and in the eye, as well as decreasing heart rate and relaxing the smooth muscles of blood vessels.
The breakdown of acetylcholine after it has performed its task is vital. To stop receptors from being constantly activated, and to allow repeat signals to be sent to the same site, theacetylcholine must be removed from the binding site so the receptor is ready to receive more signals. The body uses enzymes, cholinesterases, to break up the acetylcholine, using water to cleave chemical bonds and leave two compounds, acetate and choline, neither of which will interact with the receptor site; in other words, going back to our ‘lock and key’ analogy (see page here ), the key is removed from the lock, leaving it ready for the next one to enter.
The human body has two types of cholinesterase enzymes: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). AChE acts almost exclusively on acetylcholine, and is predominantly found in the muscles and brain. The body contains more of the BChE enzyme, though, which is distributed throughout the body. The BChE lock can be opened by several different molecular keys, whereas the AChE lock is specific to the acetylcholine one. BChE acts on a range of compounds, including aspirin, cocaine and heroin, breaking them down and limiting the amount of cholinergic 50 toxins that can reach the brain.
Eserine binds to AChE as if it were acetylcholine, but the structural differences between the two compounds means a different chemical reaction then takes place. The eserine is broken up by the enzyme but only slowly, and in the process a fragment of the eserine structure known as a carbamate unit is transferred to the active site of the enzyme. With the carbamate present, the enzyme cannot carry out its normal function and is effectively inactive. It is as though a key has broken in the lock and a fragment of it has got stuck, so that no other keys will fit in the lock until the fragment is removed. The enzyme can be regenerated by having the carbamate removed by another enzyme, but this process is also slow. While the AChE is out of action, acetylcholine will continue to interact with the nerve receptors, and will stimulate them.
Eserine is classified as
Similar Books
